Fang Zhang

Vice President, Business Development at Pioneering Medicines

Presenter

Flagship Pioneering is a biotechnology company that invents and builds platform companies, each with the potential for multiple products that transform human health or sustainability. Since its launch in 2000, Flagship has originated and fostered more than 100 scientific ventures, resulting in more than $75 billion in aggregate value. Pioneering Medicines is Flagship’s in house drug discovery and development unit. Pioneering Medicines was formed to accelerate the creation of novel therapeutics and maximize the value creation and patient impact of Flagship’s first-in-category bioplatforms. We’re here to make new medicines for patients, sooner. Our team of drug development experts creates new therapeutics built from Flagship’s innovative bioplatforms and novel modalities. More than 40 companies across the Flagship ecosystem are pioneering innovative platform technologies to address major challenges in human health. Pioneering Medicines explores and identifies new product concepts and then works jointly with Flagship’s companies to form integrated teams that advance medicines through robust discovery and early clinical development. Pioneering Medicines also partners with external collaborators across biopharma throughout our R&D process. We apply our unique approach to the R&D priorities of our partners through highly co-creative relationships that draw on the expertise of our respective teams.